Invention Grant
- Patent Title: Use of NK-1 receptor antagonists in pruritus
- Patent Title (中): 在瘙痒症中使用NK-1受体拮抗剂
-
Application No.: US14312942Application Date: 2014-06-24
-
Publication No.: US09198898B2Publication Date: 2015-12-01
- Inventor: Xiaoming Zhang , Edward F. Schnipper , Andrew J. Perlman , James W. Larrick
- Applicant: TIGERCAT PHARMA, INC.
- Applicant Address: US CA South San Francisco
- Assignee: TIGERCAT PHARMA, INC.
- Current Assignee: TIGERCAT PHARMA, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: The Marbury Law Group, PLLC
- Main IPC: A61K31/4035
- IPC: A61K31/4035 ; A61K45/06
Abstract:
The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.
Public/Granted literature
- US20150057255A1 USE OF NK-1 RECEPTOR ANTAGONISTS IN PRURITUS Public/Granted day:2015-02-26
Information query
IPC分类:
